Cargando…
A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases
BACKGROUNDS: Cancer-related mortality in patients with colorectal cancer (CRC) is predominantly caused by development of colorectal liver metastases (CLMs). How to screen the sensitive chemotherapy and targeted therapy is the key element to improve the prognosis of CLMs patients. The study aims to d...
Autores principales: | Jian, Mi, Ren, Li, He, Guodong, Lin, Qi, Tang, Wentao, Chen, Yijiao, Chen, Jingwen, Liu, Tianyu, Ji, Meiling, Wei, Ye, Chang, Wenju, Xu, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291745/ https://www.ncbi.nlm.nih.gov/pubmed/32532289 http://dx.doi.org/10.1186/s12967-020-02407-8 |
Ejemplares similares
-
Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis
por: Jian, Mi, et al.
Publicado: (2019) -
Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
por: Zheng, Peng, et al.
Publicado: (2018) -
Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression
por: Liu, Yu, et al.
Publicado: (2022) -
Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study
por: Chang, Wenju, et al.
Publicado: (2023) -
The Combination of Neoadjuvant Therapy and Surgical Resection: A Safe and Effective Treatment for Rectal Gastrointestinal Stromal Tumors
por: Liu, Yu, et al.
Publicado: (2021)